Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | IMC-C103C |
Trade Name | |
Synonyms | IMC C103C|IMC C103C |
Drug Descriptions |
IMC-C103C is a T-cell receptor (TCR) that targets MAGEA4 and is fused with an anti-CD3 single-chain variable fragment (NCI Thesaurus). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C162462 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Atezolizumab + IMC-C103C | Atezolizumab IMC-C103C | 0 | 1 |
IMC-C103C | IMC-C103C | 0 | 1 |